VeriSIM Life announces recognition for continued advances with BIOiSIM, a first-in-class virtual drug development engine.
VeriSIM Life— the leading artificial intelligence (AI)-enabled, unique R&D decisions...
A global consortium of scientists from federal laboratories, research institutes, academia, and industry has formed to address the challenges of building large-scale artificial intelligence (AI) systems...
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, announced that they have updated the focus...
Certis Oncology Solutions (Certis), a translational science and precision oncology company, announced it has been selected as "Overall Immunology Company of the Year" in...
Investment supported by additional financing from a strong syndicate of new and existing institutional investors, along with industry leaders
Terray Therapeutics, a biotechnology company integrating...
Osmo, a machine olfaction startup, announced the receipt of a $3.5 million grant from the Bill & Melinda Gates Foundation to advance the company's AI-enabled scent...
Alimentiv Inc., AcelaBio Inc. and PharmaNest Inc. announce a collaboration to provide precision medicine and artificial intelligence (AI)-powered digital pathology solutions for metabolic dysfunction-associated...
bit.bio, the company coding human cells for novel cures, announced its cell therapy pipeline and declared its lead cell therapy candidate as it prepares to...
To help life sciences companies create sustainable value and drive growth, Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud...
Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient accessibility and safety
908 Devices...